Quarterly ResultMay 13, 2026, 04:52 PM
OACC Q1 Net Income $1.39M; Going Concern Doubt
AI Summary
Oaktree Acquisition Corp. III Life Sciences reported a net income of $1.39 million for the three months ended March 31, 2026, a decrease from $1.66 million in the prior year. The blank check company continues its search for a business combination target, with $203.41 million held in its Trust Account. However, management has identified substantial doubt about its ability to continue as a going concern if a business combination is not completed by October 25, 2026.
Key Highlights
- Net income for Q1 2026 was $1.39 million, down from $1.66 million in Q1 2025.
- Basic and diluted EPS for Class A shares was $0.06 in Q1 2026, down from $0.07 in Q1 2025.
- Cash held in Trust Account increased to $203.41 million as of March 31, 2026.
- Total assets were $204.83 million as of March 31, 2026, up from $203.11 million at year-end 2025.
- Total liabilities were $8.64 million as of March 31, 2026, compared to $8.32 million at year-end 2025.
- Accumulated deficit grew to $(7.23) million as of March 31, 2026.
- Working capital deficit was $(207,947) as of March 31, 2026.
- Company faces substantial doubt about going concern if no business combination by October 25, 2026.